Drug
TD 1211 Dose 1
TD 1211 Dose 1: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-1211 Dose 1 NCT01655771 | Phase 1 | Constipation |
Latest
No recent events.
Follow TD 1211 Dose 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.